• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Targeting high-risk populations.

作者信息

Jönsson B

机构信息

Department of Economics, Stockholm School of Economics, Sweden.

出版信息

Osteoporos Int. 1998;8 Suppl 1:S13-6.

PMID:9682791
Abstract
摘要

相似文献

1
Targeting high-risk populations.针对高危人群。
Osteoporos Int. 1998;8 Suppl 1:S13-6.
2
Evidence-based assessment of pharmaceutical interventions.药物干预措施的循证评估
Osteoporos Int. 1998;8 Suppl 1:S17-21.
3
Intervention thresholds for the treatment of osteoporosis: comparison of different approaches to decision-making.骨质疏松症治疗的干预阈值：不同决策方法的比较
Osteoporos Int. 1998;8 Suppl 1:S22-7.
4
Health-economic comparison of three recommended drugs for the treatment of osteoporosis.三种推荐用于治疗骨质疏松症的药物的卫生经济学比较
Int J Clin Pharmacol Res. 2004;24(1):1-10.
5
[Evaluation of the effects of treatment of osteoporosis].[骨质疏松症治疗效果评估]
Ugeskr Laeger. 2005 Feb 28;167(9):1031-3.
6
Prevention of osteoporotic hip fracture: global versus high-risk strategies.骨质疏松性髋部骨折的预防：全球策略与高危策略
Osteoporos Int. 1998;8 Suppl 1:S2-7.
7
[Therapy of osteoporosis. Risk factors alone are not an indication].[骨质疏松症的治疗。仅风险因素并非治疗指征]
MMW Fortschr Med. 2001 Dec 6;143(49-50):57.
8
[Patients' and population's knowledge of osteoporosis].[患者及公众对骨质疏松症的认知]
Ugeskr Laeger. 2005 Jan 17;167(3):282-5.
9
[Cost-effectiveness of alendronate treatment of osteoporosis in Denmark. An economic evaluation based on the Fracture Intervention Trial].[丹麦阿仑膦酸钠治疗骨质疏松症的成本效益。基于骨折干预试验的经济评估]
Ugeskr Laeger. 2003 Oct 20;165(43):4112-6.
10
[Economic expenditures of different intervention regimes in the prevention of hip fractures].
Ugeskr Laeger. 1999 Sep 20;161(38):5327-8.

引用本文的文献

1
Data-Driven Risk Assessment from Small Scale Epidemics: Estimation and Model Choice for Spatio-Temporal Data with Application to a Classical Swine Fever Outbreak.小规模疫情的数据驱动风险评估：时空数据的估计与模型选择及其在经典猪瘟疫情中的应用
Front Vet Sci. 2017 Feb 28;4:16. doi: 10.3389/fvets.2017.00016. eCollection 2017.
2
Risk factors for osteoporosis and fractures in postmenopausal women between 50 and 65 years of age in a primary care setting in Spain: a questionnaire.西班牙基层医疗环境中50至65岁绝经后女性骨质疏松症和骨折的危险因素：一项问卷调查
Open Rheumatol J. 2008;2:58-63. doi: 10.2174/1874312900802010058. Epub 2008 Nov 14.
3
An economic evaluation of strontium ranelate in the treatment of osteoporosis in a Swedish setting: based on the results of the SOTI and TROPOS trials.
瑞典环境下雷奈酸锶治疗骨质疏松症的经济学评估：基于SOTI和TROPOS试验结果
Osteoporos Int. 2006 Dec;17(12):1781-93. doi: 10.1007/s00198-006-0193-z. Epub 2006 Sep 29.
4
Economic evaluations of interventions for the prevention and treatment of osteoporosis: a structured review of the literature.骨质疏松症预防和治疗干预措施的经济学评估：文献的结构化综述
Osteoporos Int. 2006 Jan;17(1):29-40. doi: 10.1007/s00198-005-1943-z. Epub 2005 Jun 25.
5
Cost effectiveness of alendronate (fosamax) for the treatment of osteoporosis and prevention of fractures.阿仑膦酸钠（福善美）治疗骨质疏松症及预防骨折的成本效益
Pharmacoeconomics. 2003;21(5):305-14. doi: 10.2165/00019053-200321050-00002.
6
Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry.骨质疏松症风险评估工具的开发与验证，以促进对女性进行骨密度测量的筛选。
CMAJ. 2000 May 2;162(9):1289-94.